Discovery of toll-like receptors 7 (TLR7) antagonists to minimise the risk of COVID infection in rheumatoid arthritis via virtual screening approaches
Journal of Phytonanotechnology and Pharmaceutical Sciences · 2022
DOI: 10.54085/jpps.2022.2.4.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Phytonanotechnology and Pharmaceutical Sciences, 2022. Verfasst von P. Dakshinesh und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dakshinesh, P., Selvinthanuja, C., Dharanikumar, K., Boopathiraj, T., Gunaseelan, M., Sanjai, V., Sivakumar, T., & Prabha, T. (2022). Discovery of toll-like receptors 7 (TLR7) antagonists to minimise the risk of COVID infection in rheumatoid arthritis via virtual screening approaches. Journal of Phytonanotechnology and Pharmaceutical Sciences. https://doi.org/10.54085/jpps.2022.2.4.3
Vancouver
Dakshinesh P, Selvinthanuja C, Dharanikumar K, Boopathiraj T, Gunaseelan M, Sanjai V, et al. Discovery of toll-like receptors 7 (TLR7) antagonists to minimise the risk of COVID infection in rheumatoid arthritis via virtual screening approaches. Journal of Phytonanotechnology and Pharmaceutical Sciences. 2022. doi:10.54085/jpps.2022.2.4.3
BibTeX
@article{Dakshinesh2022,
author = {Dakshinesh, P. and Selvinthanuja, C. and Dharanikumar, K. and Boopathiraj, T. and Gunaseelan, M. and Sanjai, V. and Sivakumar, T. and Prabha, T.},
title = {Discovery of toll-like receptors 7 (TLR7) antagonists to minimise the risk of COVID infection in rheumatoid arthritis via virtual screening approaches},
journal = {Journal of Phytonanotechnology and Pharmaceutical Sciences},
year = {2022},
doi = {10.54085/jpps.2022.2.4.3}
}
EUVIMED